Bio Sequence

A Detailed Approach to Locating Patent Information for Your Specific Antibody Sequence

20 September 2023
2 min read

To acquire patent data related to a delineated antibody sequence, the Patsnap Bio Sequence Database is an optimal resource for conducting a systematic search. This database encompasses a voluminous and diverse assortment of patent literature and associated sequence data derived from such literature, enabling highly accurate and comprehensive patent searches that focus on antibody sequences. This is carried out via the database's dedicated antibody retrieval extension. Furthermore, the Bio database is equipped with tools specially designed for the antibody landscape, enabling analysis of potential sequence duplications in the antibody sequence's Complementarity-Determining Region (CDR). The database thereby aligns closely with the requirements of both researchers and intellectual property professionals. Here's a detailed overview of the procedure:

1.If the antibody’s CDR does not require a duplication check, input the antibody sequence using the standard operation to extract the sequence patent. Based on the resultant patent, relevant patent literature can be further identified.

2. If the search necessitates a review of the antibody’s CDR, the specialized antibody section in the Bio database is a recommended resource. 

1) Begin by inputting the antibody sequence in the sequence box, discriminating between light and heavy chains, and selecting the respective CDR computation rules. These automatically fill in the CDR, allowing the search to proceed.

图形用户界面, 应用程序

描述已自动生成

2) By selecting the CDR-involved area, you can define the scope of the patent and enter.

图形用户界面

描述已自动生成

3) Then go to the specific patent to view the related content of the patent.

It is important to note that Patsnap Bio is the most extensive sequence search platform for the Patsnap database. It incorporates AI with human-curated data for comprehensive handling of protein and nucleotide sequence data plucked from global patents, biological periodicals, and public repositories. Essential biological sequences are manually annotated, illuminating structural modifications to provide the most accurate sequence data and boost sequence retrieval efficiency.

Free registration is available for the Bio biological sequence database: https://bio.patsnap.com. Act now to expedite your sequence search tasks.

The initiation patient treatment in Phase 2 clinical trials of Bempikibart for Alopecia Areata has been announced by Q32 Bio and Horizon Therapeutics plc
Latest Hotspot
3 min read
The initiation patient treatment in Phase 2 clinical trials of Bempikibart for Alopecia Areata has been announced by Q32 Bio and Horizon Therapeutics plc
20 September 2023
IQ32 Bio and Horizon Therapeutics initiated a Phase 2 trial for bempikibart's effectiveness against severe adult alopecia areata.
Read →
Progress in the Research of COX-1 Inhibitors
Progress in the Research of COX-1 Inhibitors
20 September 2023
Cyclooxygenase, also known as Prostaglandin-endoperoxide Synthase, is a bifunctional enzyme with both cyclooxygenase and peroxidase activity.
Read →
RS Oncology Reports New Preclinical Evidence Show RSO-021 Could Halt and/or Revert the Advancement of Severe Mesotheliomas
Latest Hotspot
3 min read
RS Oncology Reports New Preclinical Evidence Show RSO-021 Could Halt and/or Revert the Advancement of Severe Mesotheliomas
20 September 2023
At the 2023 IASLC World Lung Cancer Conference in Singapore, RS Oncology shared a first-of-its-kind PRX3 inhibitor, RSO-021's potential to combat swift mesothelioma tumor progression.
Read →
Progress in the Research of COMT Inhibitors
Progress in the Research of COMT Inhibitors
20 September 2023
Catechol O-methyltransferase (COMT) is an enzyme responsible for the O-methylation of endogenous neurotransmitters, xenobiotics, and hormones with catechol structures.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.